Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DnaJ homolog subfamily B member 12 (DNAJB12) is an endoplasmic reticulum (ER)-resident co-chaperone belonging to the Hsp40 family [1]. It functions primarily by recruiting Hsp70 chaperones to nascent or misfolded polypeptides, facilitating their proper folding or directing them toward ER-associated degradation (ERAD) [1, 3]. In the context of viral pathogenesis, DNAJB12 has been identified as a critical host factor for the Hepatitis B virus (HBV), where it assists in the assembly and secretion of both infectious virions and non-infectious subviral particles (SVPs) [2]. It specifically interacts with HBV surface proteins (HBsAg) to ensure their correct maturation and exit from the ER [3]. Because the secretion of HBsAg is a hallmark of chronic HBV infection and contributes to immune exhaustion, DNAJB12 is considered a potential host-targeting therapeutic target [2, 3]. Targeting this protein could reduce the viral burden and restore immune responses, although the essential role of DNAJB12 in cellular protein quality control poses a challenge for maintaining a favorable safety profile.
DNAJB12 acts as a co-chaperone that facilitates the proper folding and assembly of Hepatitis B virus (HBV) surface proteins within the endoplasmic reticulum. By inhibiting DNAJB12, the maturation and subsequent secretion of subviral particles (SVPs) and infectious virions are disrupted, leading to a reduction in circulating viral antigens and viral load.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DnaJ homolog subfamily B member 12 (DNAJB12) (DNAJB12).